E
Sell
11/12/2024Downgrade
Ayurcann Holdings Corp. (AYURF) was downgraded to E+ from D- on 11/12/2024 due to a significant decline in the growth index, valuation index and solvency index. Earnings per share declined from -$0.0013 to -$0.01, EBIT declined 643.48% from -$226.3 to -$1.68M, and operating cash flow declined 394.94% from $842.3 to -$2.48M.
D
Sell
7/24/2024Upgraded
Ayurcann Holdings Corp. (AYURF) was upgraded to D- from E+ on 7/24/2024 due to an increase in the total return index and valuation index.
E
Sell
7/9/2024Downgrade
Ayurcann Holdings Corp. (AYURF) was downgraded to E+ from D- on 7/9/2024 due to a decline in the valuation index.
D
Sell
4/18/2024Upgraded
Ayurcann Holdings Corp. (AYURF) was upgraded to D- from E+ on 4/18/2024 due to an increase in the total return index and volatility index.
E
Sell
11/6/2023Downgrade
Ayurcann Holdings Corp. (AYURF) was downgraded to E+ from D- on 11/6/2023 due to a significant decline in the valuation index, efficiency index and solvency index. Net income declined 202.66% from -$776.8 to -$2.35M, debt to equity increased from 0.1 to 0.2, and total capital declined 47.3% from $4.71M to $2.48M.
D
Sell
7/1/2022Upgraded
Ayurcann Holdings Corp. (AYURF) was upgraded to D- from E on 7/1/2022 due to a significant increase in the valuation index and efficiency index.
E
Sell
4/1/2022Upgraded
Ayurcann Holdings Corp. (AYURF) was upgraded to E from E- on 4/1/2022 due to an increase in the growth index, total return index and solvency index. EBIT increased 339.55% from $102.4 to $450.1, total revenue increased 72.56% from $1.48M to $2.56M, and debt to equity declined from 0.04 to 0.02.
E
Sell
12/28/2021None
Ayurcann Holdings Corp. (AYURF) was downgraded to E- from U on 12/28/2021.
